Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Enterococcus gallinarum + Pembrolizumab & Solid tumors

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

For the open label phase I/II treatment trial NCT03637803 - Enterococcus gallinarum MRx0518 + Pembrolizumab & Solid tumors no published results were available as of February 2026

…

283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs)
Pant et al. 2020 Journal for ImmunoTherapy of Cancer 8:
A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients who have progressed on prior anti-PD-1 therapy
Pant et al. 2019 J Clin Oncol : TPS2670-TPS2670

7/1/2026